Stock WDH1 DEMANT A/S
Add to a list
To use this feature you must be a member
Log inSign up

Financials Demant A/S Börse Stuttgart

Equities

WDH1

DK0060738599

Medical Equipment, Supplies & Distribution

Real-time Estimate Tradegate
Other stock markets
 11:30:44 26/06/2024 pm IST 		5-day change 1st Jan Change
41.5 EUR +0.39% Intraday chart for Demant A/S -2.27% +4.39%
09:36am Demant Flags Delay in Completion of Communications Business' Strategic Review MT
29/05 UK’s Competition Regulator Closes Cochlear-Demant Deal MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 51,461 57,664 80,200 42,434 64,150 67,140 - -
Enterprise Value (EV) 1 57,682 64,799 89,350 55,145 76,430 80,708 80,390 79,929
P/E ratio 35 x 51.4 x 31.3 x 20.9 x 36.8 x 22.1 x 18.5 x 16 x
Yield - - - - - - - -
Capitalization / Revenue 3.44 x 3.99 x 4.36 x 2.15 x 2.86 x 2.89 x 2.69 x 2.49 x
EV / Revenue 3.86 x 4.48 x 4.86 x 2.8 x 3.41 x 3.47 x 3.22 x 2.97 x
EV / EBITDA 18.5 x 25.1 x 19.7 x 12.6 x 13.9 x 13.1 x 12 x 11 x
EV / FCF 43.1 x 32 x 35.4 x 34.1 x 21.9 x 25.4 x 22.8 x 19.8 x
FCF Yield 2.32% 3.12% 2.83% 2.93% 4.56% 3.93% 4.38% 5.04%
Price to Book 6.68 x 6.99 x 9.67 x 5.02 x 7.07 x 6.59 x 5.47 x 4.46 x
Nbr of stocks (in thousands) 2,45,287 2,39,666 2,39,330 2,20,381 2,16,722 2,17,703 - -
Reference price 2 209.8 240.6 335.1 192.6 296.0 308.4 308.4 308.4
Announcement Date 04/02/20 09/02/21 08/02/22 07/02/23 05/02/24 - - -
1DKK in Million2DKK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 14,946 14,469 18,388 19,705 22,443 23,226 24,970 26,925
EBITDA 1 3,110 2,578 4,536 4,383 5,482 6,139 6,715 7,291
EBIT 1 2,151 1,313 3,386 3,207 4,148 4,772 5,241 5,708
Operating Margin 14.39% 9.07% 18.41% 16.28% 18.48% 20.55% 20.99% 21.2%
Earnings before Tax (EBT) 1 1,911 1,336 3,243 2,927 3,394 4,041 4,615 5,155
Net income 1 1,462 1,121 2,513 2,082 1,795 3,038 3,520 3,958
Net margin 9.78% 7.75% 13.67% 10.57% 8% 13.08% 14.1% 14.7%
EPS 2 6.000 4.680 10.70 9.210 8.040 13.96 16.64 19.30
Free Cash Flow 1 1,338 2,023 2,525 1,617 3,483 3,176 3,523 4,029
FCF margin 8.95% 13.98% 13.73% 8.21% 15.52% 13.67% 14.11% 14.96%
FCF Conversion (EBITDA) 43.02% 78.47% 55.67% 36.89% 63.54% 51.73% 52.46% 55.25%
FCF Conversion (Net income) 91.52% 180.46% 100.48% 77.67% 194.04% 104.54% 100.07% 101.8%
Dividend per Share 2 - - - - - - - -
Announcement Date 04/02/20 09/02/21 08/02/22 07/02/23 05/02/24 - - -
1DKK in Million2DKK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2019 S2 2020 S1 2020 S2 2021 S1 2021 S2 2022 Q2 2022 S1 2022 Q4 2022 S2 2023 Q2 2023 S1 2023 Q3 2023 Q4 2023 S2 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2024 S2
Net sales 1 7,596 6,078 8,391 9,012 9,376 4,894 9,497 5,345 10,208 5,647 11,155 5,403 5,885 11,288 5,575 5,867 11,347 5,687 6,192 11,959
EBITDA 1,528 629 1,949 2,162 2,374 893 2,128 - 2,255 - 2,662 - - 2,820 - - - - - -
EBIT 1,038 -193 1,506 1,638 1,748 - 1,588 - 1,619 - 2,014 - - 2,134 - - 2,180 - - 2,572
Operating Margin 13.67% -3.18% 17.95% 18.18% 18.64% - 16.72% - 15.86% - 18.05% - - 18.91% - - 19.21% - - 21.51%
Earnings before Tax (EBT) 917 26 1,310 1,536 1,707 - 1,493 - 1,434 - 1,655 - - 1,739 - - 1,900 - - 2,161
Net income 699 119 1,013 1,174 1,339 - 1,049 - 1,033 - 581 - - 1,214 - - - - - -
Net margin 9.2% 1.96% 12.07% 13.03% 14.28% - 11.05% - 10.12% - 5.21% - - 10.75% - - - - - -
EPS 2.880 0.5000 4.180 4.940 5.760 - 4.600 - 4.610 - - - - 5.440 - - - - - -
Dividend per Share - - - - - - - - - - - - - - - - - - - -
Announcement Date 04/02/20 17/08/20 09/02/21 12/08/21 08/02/22 16/08/22 16/08/22 07/02/23 07/02/23 15/08/23 15/08/23 07/11/23 05/02/24 05/02/24 - - - - - -
1DKK in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 6,221 7,135 9,150 12,711 12,280 13,568 13,251 12,789
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 2 x 2.768 x 2.017 x 2.9 x 2.24 x 2.21 x 1.973 x 1.754 x
Free Cash Flow 1 1,338 2,023 2,525 1,617 3,483 3,176 3,523 4,029
ROE (net income / shareholders' equity) 19.5% 14.3% 30.7% 25.2% 28.5% 31.1% 31.1% 29.4%
ROA (Net income/ Total Assets) 7.36% 5.13% 10.7% 7.61% 8.45% 9.81% 10.8% 11.5%
Assets 1 19,867 21,852 23,394 27,359 21,243 30,958 32,495 34,365
Book Value Per Share 2 31.40 34.40 34.70 38.40 41.90 46.80 56.40 69.10
Cash Flow per Share 2 8.820 10.90 13.90 11.60 19.40 18.60 21.40 23.60
Capex 1 571 507 558 630 633 912 1,015 1,161
Capex / Sales 3.82% 3.5% 3.03% 3.2% 2.82% 3.93% 4.06% 4.31%
Announcement Date 04/02/20 09/02/21 08/02/22 07/02/23 05/02/24 - - -
1DKK in Million2DKK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Demant A/S

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
308.4 DKK
Average target price
336.7 DKK
Spread / Average Target
+9.17%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Prosthetics

1st Jan change Capi.
STRAUMANN HOLDING AG Stock Straumann Holding AG
-17.11% 19.5B
SONOVA HOLDING AG Stock Sonova Holding AG
+0.15% 18.1B
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD. Stock Eyebright Medical Technology (Beijing) Co., Ltd.
-19.33% 1.9B
EMBLA MEDICAL HF. Stock Embla Medical hf.
+2.37% 1.72B
ANGELALIGN TECHNOLOGY INC. Stock Angelalign Technology Inc.
+2.12% 1.24B
MODERN DENTAL GROUP LIMITED Stock Modern Dental Group Limited
+2.09% 525M
ANGEL ROBOTICS CO., LTD. Stock Angel Robotics Co., Ltd.
0.00% 372M
DELCATH SYSTEMS, INC. Stock Delcath Systems, Inc.
+92.31% 231M
INTEGRUM AB Stock Integrum AB
+16.54% 99.2M
Medical Prosthetics
  1. Stock Market
  2. Equities
  3. DEMANT Stock
  4. WDH1 Stock
  5. Financials Demant A/S